REGINfo: Sanofi-Aventis - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
- Remgro
- RICHEMONT
- RMB Holdings
- Sanlam
- Sasol
- Shoprite
- Standard Bank Group
- Tiger Brands
- Vodacom Group
- WOOLWORTHS
> TA 25
Israel - TA 25
- AVNER OIL
- AZRIELI GROUP
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- ICL
- IFF
- ISRAEL CORP
- KENON
- LEUMI
- MIGDAL INSURANCE
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- OSEM
- PAZ OIL
- PERRIGO
- POALIM
- STRAUSS GROUP
- TEVA

Europe

COMPANY SEARCH RESULT

$Sanofi-Aventis: Click to view the issuer\'s details$

Last update : 29/03/2019 >View issuer details

2019.10.21 | 19:28 | Share History / Voting Rights and Number of Shares

puce Sanofi: information concerning the total number of voting rights and shares, September 2019 - HTML (w)

2019.10.21 | 19:28 | Share History / Voting Rights and Number of Shares

puce Sanofi : informations relatives au nombre total de droits de vote et d’actions, septembre 2019 - HTML (w)

2019.10.15 | 07:00 | Permanent Information Releases / General Company News

puce Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing - HTML (w)

2019.10.15 | 07:00 | Permanent Information Releases / General Company News

puce Sanofi inaugure sa première usine digitale de fabrication en continu et ouvre la voie à la prochaine génération de sites de production de biomédicaments - HTML (w)

2019.10.01 | 22:30 | Permanent Information Releases / Notification of availability

puce Sanofi : Availability of the Pre-quarterly Results Communication - HTML (w)

2019.10.01 | 22:30 | Permanent Information Releases / Notification of availability

puce Sanofi : Mise en ligne du document «Pre-quarterly Results Communication » - HTML (w)

2019.09.30 | 16:30 | Permanent Information Releases / General Company News

puce Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer - HTML (w)

2019.09.30 | 16:30 | Permanent Information Releases / General Company News

puce Sanofi : Le New England Journal of Medicine publie des données montrant que Jevtana® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne dans le traitement du cancer de la prosta - HTML (w)

2019.09.20 | 12:48 | Permanent Information Releases / General Company News

puce Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis - HTML (w)

2019.09.20 | 12:48 | Permanent Information Releases / General Company News

puce Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère - HTML (w)

2019.09.16 | 18:00 | Share History / Voting Rights and Number of Shares

puce Sanofi: information concerning the total number of voting rights and shares, August 2019 - HTML (w)

2019.09.16 | 18:00 | Share History / Voting Rights and Number of Shares

puce Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019 - HTML (w)

2019.09.16 | 07:00 | Permanent Information Releases / General Company News

puce Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed - HTML (w)

2019.09.16 | 07:00 | Permanent Information Releases / General Company News

puce Sanofi et Abbott s’associent pour intégrer les technologies de mesure de la glycémie et d’administration d’insuline afin de transformer la prise en charge du diabète - HTML (w)

2019.08.28 | 22:35 | Permanent Information Releases / General Company News

puce Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9 - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 2734